Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Change in Receivables (2020 - 2025)

Historic Change in Receivables for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $1.3 million.

  • SOPHiA GENETICS's Change in Receivables rose 7237.35% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 99326.42%. This contributed to the annual value of $5.9 million for FY2024, which is 19064.62% up from last year.
  • SOPHiA GENETICS's Change in Receivables amounted to $1.3 million in Q3 2025, which was up 7237.35% from $1.7 million recorded in Q2 2025.
  • SOPHiA GENETICS's Change in Receivables' 5-year high stood at $3.0 million during Q4 2021, with a 5-year trough of -$3.6 million in Q4 2023.
  • Over the past 5 years, SOPHiA GENETICS's median Change in Receivables value was $262000.0 (recorded in 2021), while the average stood at $134789.5.
  • Per our database at Business Quant, SOPHiA GENETICS's Change in Receivables surged by 47837.15% in 2021 and then plummeted by 15835000.0% in 2023.
  • Over the past 5 years, SOPHiA GENETICS's Change in Receivables (Quarter) stood at $3.0 million in 2021, then plummeted by 31.91% to $2.0 million in 2022, then tumbled by 278.77% to -$3.6 million in 2023, then surged by 157.43% to $2.1 million in 2024, then plummeted by 36.08% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.7 million for Q2 2025, and -$3.0 million during Q1 2025.